MYCN and neuroblastoma: To test this hypothesis, we investigated the association of genetic determinants of stature and risk of neuroblastoma, stratifying analyses by MYCN‐amplification status given previous studies identifying non‐overlapping genetic risk variants underlying MYCN‐amplified vs MYCN‐unamplified neuroblastoma risk.